Abstract:Background: Excitation-contraction (E-C) coupling processes become disrupted in heart failure (HF), resulting in abnormal Ca2+ homeostasis, maladaptive structural and transcriptional remodeling, and cardiac dysfunction. Junctophilin-2 (JP2) is an essential component of the E-C coupling apparatus but becomes site-specifically cleaved by calpain, leading to disruption of E-C coupling, plasmalemmal transverse tubule degeneration, abnormal Ca2+ homeostasis, and HF. However, it is not clear whether preventing site-specific calpain cleavage of JP2 is sufficient to protect the heart against stress-induced pathological cardiac remodeling in vivo. Methods: Calpain-resistant JP2 knock-in mice (JP2CR) were generated by deleting the primary JP2 calpain cleavage site. Stress-dependent JP2 cleavage was assessed through in vitro cleavage assays and in isolated cardiomyocytes treated with 1 μmol/L isoproterenol by immunofluorescence. Cardiac outcomes were assessed in wild-type and JP2CR mice 5 weeks after transverse aortic constriction compared with sham surgery using echocardiography, histology, and RNA-sequencing methods. E-C coupling efficiency was measured by in situ confocal microscopy. E-C coupling proteins were evaluated by calpain assays and Western blotting. The effectiveness of adeno-associated virus gene therapy with JP2CR, JP2, or green fluorescent protein to slow HF progression was evaluated in mice with established cardiac dysfunction. Results: JP2 proteolysis by calpain and in response to transverse aortic constriction and isoproterenol was blocked in JP2CR cardiomyocytes. JP2CR hearts are more resistant to pressure-overload stress, having significantly improved Ca2+ homeostasis and transverse tubule organization with significantly attenuated cardiac dysfunction, hypertrophy, lung edema, fibrosis, and gene expression changes relative to wild-type mice. JP2CR preserves the integrity of calpain-sensitive E-C coupling-related proteins, including ryanodine receptor 2, CaV1.2, and sarcoplasmic reticulum calcium ATPase 2a, by attenuating transverse aortic constriction-induced increases in calpain activity. Furthermore, JP2CR gene therapy after the onset of cardiac dysfunction was found to be effective at slowing the progression of HF and superior to wild-type JP2. Conclusions: The data presented here demonstrate that preserving JP2-dependent E-C coupling by prohibiting the site-specific calpain cleavage of JP2 offers multifaceted beneficial effects, conferring cardiac protection against stress-induced proteolysis, hypertrophy, and HF. Our data also indicate that specifically targeting the primary calpain cleavage site of JP2 by gene therapy approaches holds great therapeutic potential as a novel precision medicine for treating HF.

Structural and functional remodeling of excitation-contraction coupling mediated by junctophilin-2 down-regulation in cardiomyocytes

Spatial Remodelling of Calcium Release Units May Impair Cardiac Electro-Mechanical Function: A Simulation Study.

Abstract 368: Structural and Molecular Mechanisms of Excitation-contraction Uncoupling in Heart Failure

JP-2 Gene Expression Affects Excitation-Contraction Coupling in the Dilated Cardiomyopathy Heart Failure

Ultrastructural uncoupling between T-tubules and sarcoplasmic reticulum in human heart failure

Junctophilin 2 Knockdown Interfere With Mitochondrium Status In Esc-Cms And Cardiogenesis Of Es Cells

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Preventing Site-Specific Calpain Proteolysis of Junctophilin-2 Protects Against Stress-Induced Excitation-Contraction Uncoupling and Heart Failure Development

Ultrastructural remodelling of Ca(2+) signalling apparatus in failing heart cells

Mir-24 regulates junctophilin-2 expression in cardiomyocytes.

Ultrastructural Remodelling of Ca2+ Signalling Apparatus in Failing Heart Cells

The structural and functional coupling between plasma membrane and sarcoplasmic reticulum in cardiac cells and its remodeling in heart diseases

Abstract 15023: Junctophilin-2 (JPH2) Interactome in Ventricular Myocytes is Subcellular Compartment-dependent and Subject to Remodeling During Hypertrophy Leading to Heart Failure

Inhibition of Histone Demethylase JMJD1C Attenuates Cardiac Hypertrophy and Fibrosis Induced by Angiotensin II

Morphogenesis of T-tubules in Heart Cells: the Role of Junctophilin-2

Conjunct Upregulation of Junctophilin-2 and Caveolin-3 Transcription Enhanced Excitation-Contraction Coupling Efficiency in Hibernating Ground Squirrels

Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.

Overexpression of KCNJ2 Enhances Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Preserved cardiac performance and adrenergic response in a rabbit model with decreased ryanodine receptor 2 expression

CYP2J deficiency leads to cardiac injury and presents dual regulatory effects on cardiac function in rats

T-tubule remodeling during transition from hypertrophy to heart failure.